AdministrationAgreement-v1.0.1(2017EN) - Bewerkingsoverzicht

Update bot op 24 dec 2018 om 11:02

2018-12-24T11:02:50Z

Update bot op 20 dec 2018 om 12:30

2018-12-20T12:30:12Z

Wijzigingen bekijken

Update bot: Copy of

2018-02-20T09:04:02Z

Copy of

Update bot op 24 jan 2018 om 15:03

2018-01-24T15:03:23Z

Update bot: Nieuwe pagina aangemaakt met '==General information== Name: '''nl.zorg.AdministrationAgreement''' link=Toedieningsafspraak-v1.0.1(2017NL)
Version: '''1.0.1'''
HCIM...'

2018-01-23T00:11:14Z

Nieuwe pagina aangemaakt met '==General information== Name: '''nl.zorg.AdministrationAgreement''' link=Toedieningsafspraak-v1.0.1(2017NL) Version: '''1.0.1''' HCIM...'

Nieuwe pagina

==General information==
Name: '''nl.zorg.AdministrationAgreement''' [[Bestand:NL.png|link=Toedieningsafspraak-v1.0.1(2017NL)]] 
Version: '''1.0.1''' 
HCIM Status:Final 
Release: '''2017''' 
Release status: Published 
Release date: 31-12-2017
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>

==Metadata==
{| class="wikitable" style="font-size:90%; width: 750px"
|-
|style="width:250px; "|DCM::CoderList||Projectgroep Medicatieproces
|-
|style="width:250px; "|DCM::ContactInformation.Address||
|-
|style="width:250px; "|DCM::ContactInformation.Name||*
|-
|style="width:250px; "|DCM::ContactInformation.Telecom||
|-
|style="width:250px; "|DCM::ContentAuthorList||Projectgroep Medicatieproces
|-
|style="width:250px; "|DCM::CreationDate||1-2-2017
|-
|style="width:250px; "|DCM::DeprecatedDate||
|-
|style="width:250px; "|DCM::DescriptionLanguage||nl
|-
|style="width:250px; "|DCM::EndorsingAuthority.Address||
|-
|style="width:250px; "|DCM::EndorsingAuthority.Name||PM
|-
|style="width:250px; "|DCM::EndorsingAuthority.Telecom||
|-
|style="width:250px; "|DCM::Id||2.16.840.1.113883.2.4.3.11.60.40.3.9.8
|-
|style="width:250px; "|DCM::KeywordList||Medicatie, Toediening
|-
|style="width:250px; "|DCM::LifecycleStatus||Final
|-
|style="width:250px; "|DCM::ModelerList||Architectuurgroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::Name||nl.zorg.Toedieningsafspraak
|-
|style="width:250px; "|DCM::PublicationDate||31-12-2017
|-
|style="width:250px; "|DCM::PublicationStatus||Published
|-
|style="width:250px; "|DCM::ReviewerList||Projectgroep Medicatieproces & Architectuurgroep Registratie aan de Bron
|-
|style="width:250px; "|DCM::RevisionDate||31-12-2017
|-
|style="width:250px; "|DCM::Superseeds||nl.zorg.MedicatieVerstrekking-v3.0
|-
|style="width:250px; "|DCM::Version||1.0.1
|-
|style="width:250px; "|HCIM::PublicationLanguage||EN
|}

==Revision History==
<div class="mw-collapsible mw-collapsed">
''Only available in Dutch''

Publicatieversie 1.0 (04-09-2017)

Publicatieversie 1.0.1 (31-12-2017)
{|
|-
|style="width:75px; "|[[ZIBIssues#ZIB-643 | ZIB-643 ]]
|Geen informatie
|}
</div>

==Concept==
An administration agreement is the use (or administering) instructions from the pharmacist to the patient (or their representative or administrator), whereby a medication agreement is structured at a concrete level.

==Purpose==
The goal of the administration agreement is to provide insight into the concrete instructions for administration/use of medication.

==Information Model==
 
<imagemap> Bestand:AdministrationAgreement-v1.0.1Model(EN).png | center
rect 614 489 899 527 [[#AdministrationAgreementAdditionalInformationCodeList]]
rect 678 385 899 455 [[#13342]]
rect 172 190 286 260 [[#13355]]
rect 172 285 301 355 [[#13345]]
rect 336 491 555 531 [[#AdministrationAgreementStopTypeCodeList]]
rect 355 99 484 169 [[InstructionsForUse-v1.1(2017EN)]]
rect 528 99 657 169 [[MedicationAgreement-v1.0.1(2017EN)]]
rect 701 99 899 169 [[PharmaceuticalProduct-v2.0(2017EN)]]
rect 769 289 899 359 [[#13344]]
rect 172 95 301 165 [[HealthcareProvider-v3.1.1(2017EN)]]
rect 419 385 579 455 [[#13341]]
rect 172 380 301 450 [[TimeInterval-v1.0(2017EN)]]
rect 740 194 899 264 [[#13349]]
rect 480 248 590 318 [[#13347]]
desc none
</imagemap>
 
{| border= "1" width="1500px" style = "font-size: 9.5pt; border: solid 1px silver; border-collapse:collapse;" cellpadding = "3px" cellspacing ="0px"
|-style="background-color: #1F497D; color: white; font-weight: bold; font-variant: small-caps; "
|style="width:30px;"|Type||style="width:100px;"|Id||colspan="6 " style="width:140px;"|Concept||Card.||style="width: 600px;"|Definition||style="width:200px;"|DefinitionCode||style="width:200px;"|Reference
|-style="vertical-align:top; background-color: #E3E3E3; "
|style = "text-align:center" |[[Bestand: block.png| 20px | link=]]
||NL-CM:9.8.20132
|colspan ="6" style ="padding-left: 0px"|[[Bestand: arrowdown.png | 10px | link=]]AdministrationAgreement
|
|Root concept of the AdministrationAgreement information model. This root concept contains all data elements of the AdministrationAgreement information model.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.8.22097
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Supplier::HealthProfessional
|0..1
|The supplier (pharmacist) that entered the administration agreement.
|
|
{|
|-
|[[Bestand: block.png | link=HealthcareProvider-v3.1.1(2017EN)]]||[[HealthcareProvider-v3.1.1(2017EN) |HealthcareProvider]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.8.20237
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]MedicineForAdministrationAgreement::FarmaceuticalProduct
|1
|Medicine in the AdministrationAgreement.
|
|
{|
|-
|[[Bestand: block.png | link=PharmaceuticalProduct-v2.0(2017EN)]]||[[PharmaceuticalProduct-v2.0(2017EN) |PharmaceuticalProduct]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.8.22098
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]InstructionsForUse
|0..1
|Instructions for administering the medication, e.g. dose and route of administration.
|
|
{|
|-
|[[Bestand: block.png | link=InstructionsForUse-v1.1(2017EN)]]||[[InstructionsForUse-v1.1(2017EN) |InstructionsForUse]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: TS.png| 16px | link=]]
||NL-CM:9.8.20133
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]AdministrationAgreementDateTime
|0..1
|The time at which the agreement was made.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:9.8.22499
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]AgreementReason
|0..1
|Reason for this agreement. This will often be the same reason as the one for the medication agreement.
This field has the option to - if applicable - enter a specific reason for the administration agreement. Examples include: substitution, transfer to GDS, patient request for different product, etc.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.8.22660
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]PeriodOfUse
|1
|Start date: This is the time at which the agreement was to take effect (or took effect or will take effect). This is the time at which the instructions for use in this agreement start. In the case of an agreement to discontinue use, this is the start date of the original administration agreement. The end date indicates from when the medication is to be discontinued.

Duration: The intended duration of use. E.g. 5 days or 8 weeks. It is not allowed to indicate the duration in months, because different months have a variable duration in days.

End date: The time at which the period of use ends (or ended or will end). In the case of an agreement to discontinue use, this is the time at which the medication is to be discontinued. To avoid confusion between 'to' and 'up to', the submission of time is always mandatory for the end date.

With medication for an indefinite period only a start date is indicated.
|
|
{|
|-
|[[Bestand: block.png | link=TimeInterval-v1.0(2017EN)]]||[[TimeInterval-v1.0(2017EN) |TimeInterval]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: Verwijzing.png| 20px | link=]]
||NL-CM:9.8.22394
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]MedicationAgreement
|0..1
|Relationship to the medication agreement on which the administration agreement is based.
|
|
{|
|-
|[[Bestand: block.png | link=MedicationAgreement-v1.0.1(2017EN)]]||[[MedicationAgreement-v1.0.1(2017EN) |MedicationAgreement]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.8.22498
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]AdministrationAgreementStopType
|0..1
|Stop type, the manner in which this medication is discontinued (temporary or definitive).
|
|
{|
|-
|[[Bestand: List2.png | link=#AdministrationAgreementStopTypeCodeList]]||[[#AdministrationAgreementStopTypeCodeList|AdministrationAgreementStopTypeCodeList]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: BL.png| 16px | link=]]
||NL-CM:9.8.23034
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]CanceledIndicator
|0..1
|In the event of an error correction, this indicator is to be put on for the incorrect agreement.
|
|
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: CD.png| 16px | link=]]
||NL-CM:9.8.23284
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]AdministrationAgreementAdditionalInformation
|0..*
|Additional information includes details on the structure of the agreement made.

This element mainly contains information that until now has been structured with ZZ rules. The medication-related topics that are now supported by the ZZ rules are best supported with a system functionality. A process has been started for this by Z-index/KNMP. For now, the following list will be used. This list will be replaced by a thesaurus in the G standard at a later stage.

|
|
{|
|-
|[[Bestand: List2.png | link=#AdministrationAgreementAdditionalInformationCodeList]]||[[#AdministrationAgreementAdditionalInformationCodeList|AdministrationAgreementAdditionalInformationCodeList]]
|}
|-style="vertical-align:top; background-color: transparent; "
|style = "text-align:center" |[[Bestand: ST.png| 16px | link=]]
||NL-CM:9.8.22275
|style = "width: 7px; padding-left: 0px; padding-right: 0px; border-left: none; border-right: 1px dotted silver;" |
|colspan ="5" style ="padding-left: 0px"|[[Bestand: arrowright.png | 10px | link=]]Comment
|0..1
|Comments on the administration agreement.
|
{|
|-
| 48767-8 Annotation comment
|}
|
|}
Columns Concept and DefinitionCode: hover over the values for more information 
For explanation of the symbols, please see the legend page [[Bestand:list2.png|link=Legend]]

==Example Instances==
''Only available in Dutch''

{|class="wikitable" width="1225px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 12%; "|ToedieningsAfspraakDatumTijd
| style="background-color: #1F497D; width: 12%; "|Gebruiksperiode
| style="background-color: #1F497D; width: 8%; "|
| style="background-color: #1F497D; width: 7%; "|
| style="background-color: #1F497D; width: 18%; "|GeneesmiddelBijToedieningsafspraak
| style="background-color: #1F497D; width: 19%; "|Verstrekker
| style="background-color: #1F497D; width: 9%; "|GeannuleerdIndicator
| style="background-color: #1F497D; width: 15%; "|ToedieningsafspraakStoptype
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 12%; "|
| style="background-color: #548DD4; width: 12%; "|Ingangsdatum
| style="background-color: #548DD4; width: 8%; "|Einddatum
| style="background-color: #548DD4; width: 7%; "|Duur
| style="background-color: #548DD4; width: 18%; "|ProductCode
| style="background-color: #548DD4; width: 19%; "|Zorgaanbieder
| style="background-color: #548DD4; width: 9%; "|
| style="background-color: #548DD4; width: 15%; "|
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 12%; "|
| style="background-color: #D9D9D9; width: 12%; "|
| style="background-color: #D9D9D9; width: 8%; "|
| style="background-color: #D9D9D9; width: 7%; "|
| style="background-color: #D9D9D9; width: 18%; "|
| style="background-color: #D9D9D9; width: 19%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 15%; "|
|-style=vertical-align:top;
| style="width: 12%; "|2-5-2012 12:14:09
| style="width: 12%; "|02-05-12
| style="width: 8%; "|
| style="width: 7%; "|4 weken
| style="width: 18%; "|Paracetamol tablet 500 mg
| style="width: 19%; "|Apotheek De Gulle Gaper
| style="width: 9%; "|
| style="width: 15%; "|
|-style=vertical-align:top;
| style="width: 12%; "|10-9-2015 9:16:31
| style="width: 12%; "|
| style="width: 8%; "|
| style="width: 7%; "|5 dagen
| style="width: 18%; "|Pantoprazol injpdr 40 mg fl
| style="width: 19%; "|Apotheek De Gulle Gaper
| style="width: 9%; "|Ja
| style="width: 15%; "|
|-style=vertical-align:top;
| style="width: 12%; "|19-9-2014 7:12:59
| style="width: 12%; "|19-09-14
| style="width: 8%; "|18-12-14
| style="width: 7%; "|
| style="width: 18%; "|Dalteparine 2500 injvlst 12.500 ie/ml wwsp 0,2ml
| style="width: 19%; "|Poli-apotheek Het Ziekenhuis
| style="width: 9%; "|
| style="width: 15%; "|
|-style=vertical-align:top;
| style="width: 12%; "|30-8-2013 8:41:43
| style="width: 12%; "|01-08-13
| style="width: 8%; "|30-08-13
| style="width: 7%; "|
| style="width: 18%; "|Prednison 5 mg
| style="width: 19%; "|Poli-apotheek Het Ziekenhuis
| style="width: 9%; "|
| style="width: 15%; "|Definitief
|}
{|class="wikitable" width="1225px" style= "font-size: 9.5pt;"
|-style=vertical-align:top;
| style="background-color: #1F497D; width: 22%; "|Gebruiksinstructie
| style="background-color: #1F497D; width: 9%; "|
| style="background-color: #1F497D; width: 11%; "|
| style="background-color: #1F497D; width: 13%; "|
| style="background-color: #1F497D; width: 13%; "|
| style="background-color: #1F497D; width: 23%; "|
| style="background-color: #1F497D; width: 8%; "|
|-style=vertical-align:top;
| style="background-color: #548DD4; width: 22%; "|Omschrijving
| style="background-color: #548DD4; width: 9%; "|ToedieningsWeg
| style="background-color: #548DD4; width: 11%; "|HerhaalperiodeCyclischSchema
| style="background-color: #548DD4; width: 13%; "|Doseerinstructie
| style="background-color: #548DD4; width: 13%; "|
| style="background-color: #548DD4; width: 23%; "|
| style="background-color: #548DD4; width: 8%; "|
|-style=vertical-align:top;
| style="background-color: #D9D9D9; width: 22%; "|
| style="background-color: #D9D9D9; width: 9%; "|
| style="background-color: #D9D9D9; width: 11%; "|
| style="background-color: #D9D9D9; width: 13%; "|Doseerduur
| style="background-color: #D9D9D9; width: 13%; "|Dosering<noWiki>|</noWiki>Keerdosis
| style="background-color: #D9D9D9; width: 23%; "|Toedieningsschema<noWiki>|</noWiki>Frequentie<noWiki>|</noWiki>Interval<noWiki>|</noWiki>Toedientijd<noWiki>|</noWiki>Weekdag<noWiki>|</noWiki>Dagdeel
| style="background-color: #D9D9D9; width: 8%; "|Zo nodig
|-style=vertical-align:top;
| style="width: 22%; "|Vanaf 2 mei gedurende 4 weken zo nodig bij pijn 500 mg (=1 st), max. 4x per dag
| style="width: 9%; "|oraal
| style="width: 11%; "|1
| style="width: 13%; "|4 weken
| style="width: 13%; "|1 stuk
| style="width: 23%; "|max. 4x/dag
| style="width: 8%; "|Bij pijn
|-style=vertical-align:top;
| style="width: 22%; "|Gedurende 5 dagen 1x/dag (8u) 40 mg (=1 st)
| style="width: 9%; "|iv
| style="width: 11%; "|
| style="width: 13%; "|
| style="width: 13%; "|40 mg (=1 st)
| style="width: 23%; "|1x per dag om 8.00 uur
| style="width: 8%; "|
|-style=vertical-align:top;
| style="width: 22%; "|Vanaf 19-9-2014 tot 18-12-2014 1x per dag om 18uur 2500ie(=0,2ml)
| style="width: 9%; "|subcutaan
| style="width: 11%; "|
| style="width: 13%; "|
| style="width: 13%; "|2500 IE (=0,2 ml)
| style="width: 23%; "|1x per dag om 18.00 uur
| style="width: 8%; "|
|-style=vertical-align:top;
| style="width: 22%; "|Van 1-8-2013 tot 30-8-2013 volgens afbouwschema. Per 30-8-2013 onderbreken.
| style="width: 9%; "|oraal
| style="width: 11%; "|1
| style="width: 13%; "|
| style="width: 13%; "|
| style="width: 23%; "|
| style="width: 8%; "|
|}

== Valuesets ==
=== AdministrationAgreementAdditionalInformationCodeList===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.2
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Geneesmiddel niet verstrekt
|1
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Geneesmiddel niet verstrekt
|-style="vertical-align:top; "
|Niet leverbaar
|2
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Niet leverbaar
|-style="vertical-align:top; "
|Medicatieafspraak gewijzigd: substantie
|3
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Medicatieafspraak gewijzigd: substantie
|-style="vertical-align:top; "
|Medicatieafspraak gewijzigd: dosering
|4
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Medicatieafspraak gewijzigd: dosering
|-style="vertical-align:top; "
|Medicatieafspraak gewijzigd: farmaceutische vorm
|5
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Medicatieafspraak gewijzigd: farmaceutische vorm
|-style="vertical-align:top; "
|Medicatieafspraak gewijzigd: verwisseling van persoon
|6
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Medicatieafspraak gewijzigd: verwisseling van persoon
|-style="vertical-align:top; "
|Machtiging aangevraagd
|7
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Machtiging aangevraagd
|-style="vertical-align:top; "
|Machtiging afgewezen
|8
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Machtiging afgewezen
|-style="vertical-align:top; "
|Machtiging in gebruik nemen
|9
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Machtiging in gebruik nemen
|-style="vertical-align:top; "
|Gebruiksinstructie gegeven
|10
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Gebruiksinstructie gegeven
|-style="vertical-align:top; "
|Controle inhalatietechniek
|11
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Controle inhalatietechniek
|-style="vertical-align:top; "
|Meter periodieke controle
|12
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Meter periodieke controle
|-style="vertical-align:top; "
|Pen controle/omruil
|13
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Pen controle/omruil
|-style="vertical-align:top; "
|Bijwerking besproken
|14
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Bijwerking besproken
|-style="vertical-align:top; "
|Afhandeling bijwerking niet-lareb
|15
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Afhandeling bijwerking niet-lareb
|-style="vertical-align:top; "
|Melding lareb
|16
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Melding lareb
|-style="vertical-align:top; "
|Medicatiebewaking OT
|17
|Voorlopige aanvullende informatie toedieningsafspraak
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.3.999
|Medicatiebewaking OT
|}

=== AdministrationAgreementStopTypeCodeList===
{| class="wikitable" width="60%"
|-style='vertical-align:top; background-color: #E8D7BE;'
|Valueset OID 2.16.840.1.113883.2.4.3.11.60.40.2.9.8.1
|}
{| class="wikitable" width="60% "
|-style="background-color: #1F497D; color: white; font-weight: bold; "
|Conceptname
|Conceptcode
|Codesystem name||Codesystem OID
|Description
|-style="vertical-align:top; "
|Tijdelijk
|1
|StopType
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1
|Tijdelijke onderbreking van medicamenteuze behandeling (bijvoorbeeld tijdelijk stoppen gebruik vanwege operatie).
|-style="vertical-align:top; "
|Definitief
|2
|StopType
|2.16.840.1.113883.2.4.3.11.60.20.77.5.2.1
|Het staken van een bestaande medicamenteuze behandeling.
|}

==This information model in other releases==
---
==More on this information model==
To exchange information based on health and care information models, additional, more technical specifications are required. 
Not every environment can handle the same technical specifications. For this reason, there are several types of technical specifications:
<ul>
<li>HL7® version 3 CDA compatible specifications, available through the Nictiz ART-DECOR® environment [http://decor.nictiz.nl/art-decor/decor-scenarios--zib2017bbr-?id=2.16.840.1.113883.2.4.3.11.60.7.4.2.9.8&effectiveDate=2017-12-31T00:00:00&language=en-US&scenariotree=false [[File:artdecor.jpg|16px|link=]]]</li>
<li>HL7® FHIR® compatible specifications, available through the Nictiz environment on the Simplifier FHIR [https://simplifier.net/NictizSTU3/~resources?text=zib&category=StructureDefinition [[File:fhir.png|link=]]]</li>
</ul>
This information model is also available as [[Media:nl.zorg.AdministrationAgreement-v1.0.1(2017EN).pdf|pdf file]] [[File:PDF.png|link=]] or as [[Media:nl.zorg.AdministrationAgreement-v1.0.1(2017EN).xlsx|spreadsheet]] [[File:xlsx.png|link=]]
==About this information==
The information in this wikipage is based on Release 2017 
Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]] 
This page is generated on 22/01/2018 00:32:10 
-----
<div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>

@@ Regel 84: / Regel 84: @@
 ==Information Model==
 <BR>
-<imagemap> Bestand:AdministrationAgreement-v1.0.1Model(EN).png | center
+<imagemap> Bestand:AdministrationAgreement-v1.0.1Model(2017EN).png | center
 rect 624 497 909 535 [[#AdministrationAgreementAdditionalInformationCodeList]]
 rect 688 393 909 463 [[#13342]]
@@ Regel 552: / Regel 552: @@
 The information in this wikipage is based on<!--ftInfoBase--> Release 2017 <BR>
 Conditions for use are located on the mainpage<!--ftConditions--> [[Bestand:list2.png|link=HCIM_Mainpage<!--wikiMainpage-->]]<BR>
-This page is generated on 19/12/2018 18:33:53 with ZibExtraction v. 3.0.6927.32850<!--ftDate--> <BR>
+This page is generated on 21/12/2018 14:11:39 with ZibExtraction v. 3.0.6929.24609<!--ftDate--> <BR>
 -----
 <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release<!--wikiReleasePage-->_2017(EN)]] [[HCIM_Release<!--wikiReleasePage-->_2017(EN) |Back to HCIM list<!--hdBackToMainPage--> ]]</div>

@@ Regel 69: / Regel 69: @@
 |-
 |style="width:75px; "|[[ZIBIssues#ZIB-643 | ZIB-643 ]]
-|Geen informatie
+|Kleine tekstuele verbeteringen
 |}
 </div>
@@ Regel 537: / Regel 537: @@
 The information in this wikipage is based on Release 2017 <BR>
 Conditions for use are located on the mainpage [[Bestand:list2.png|link=HCIM_Mainpage]]<BR>
-This page is generated on 22/01/2018 00:32:10 <BR>
+This page is generated on 24/01/2018 15:59:00 <BR>
 -----
 <div style="text-align: right; direction: ltr; margin-left: 1em;" >[[Bestand: Back 16.png| link= HCIM_Release_2017(EN)]] [[HCIM_Release_2017(EN) |Back to HCIM list ]]</div>